N-acetylaspartylglutamate in Canavan disease: an adverse effector?

A.P. Burlina, V. Ferrari, P. Divry, W. Gradowska, C.A.J.M. Jakobs, M.J. Bennett, A.C. Sewell, C. Dionisi-Vici, A.B. Burlina

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)406-409
JournalEuropean Journal of Pediatrics
Volume158
DOIs
Publication statusPublished - 1999

Cite this